Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06893016

Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight

Led by Guangdong Raynovent Biotech Co., Ltd · Updated on 2025-07-17

640

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this study is to demonstrate that RAY1225 is superior to placebo for percent change in body weight.

CONDITIONS

Official Title

Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Body mass index (BMI) of 28 kg/m2 or higher, or BMI between 24 and less than 28 kg/m2 with at least one weight-related health condition such as high blood pressure, abnormal cholesterol or triglycerides, obstructive sleep apnea, fatty liver, cardiovascular disease, or polycystic ovary syndrome
  • History of at least one unsuccessful attempt at weight loss through diet and exercise
Not Eligible

You will not qualify if you...

  • Obesity caused by genetic mutations, other diseases, or medications
  • Family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
  • History of moderate to severe depression, bipolar disorder, schizophrenia, or other severe psychiatric disorders
  • History of organ transplantation (except corneal transplant) or planned organ transplantation
  • Plans to quit smoking during the study period
  • Allergic to multiple medications or foods, or known allergy to RAY1225, GLP-1 receptor agonists, or related drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University People's Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

J

Ji, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight | DecenTrialz